Demo

News Archives

Failed Alzheimer's trial leaves families and patients heartbroken. Medical community reels

Mar 24, 2019 , CNBC Health
Biogen and Eisai lost billions of dollars in market value after halting two late-stage trials of a promising experimental Alzheimer's...
Read more

Silicon Valley techies are turning to a cheap diabetes drug to help them live longer

Mar 24, 2019 , CNBC Health
Doctors feel that taking metformin is mostly safe, but cautioned about the lack of clinical...
Read more

How a premature ejaculation drug sparked a $150 million legal battle over trade secrets

Mar 24, 2019 , CNBC Health
The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade...
Read more

Snap to drug advertisers: We're the friendlier social network

Mar 23, 2019 , CNBC Health
To win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and...
Read more

More Than 15 Percent of Providers Depart BPCI Advanced

Mar 23, 2019 , Healthcare Business News
March 21—One in seven providers in the largest Medicare bundled payment model left after five months, new data reveal. But that may be good news for the program....
Read more
Demo

'Game of Thrones' star Emilia Clarke reveals she suffered 2 life-threatening brain aneurysms

Mar 23, 2019 , CNBC Health
The news comes as the actor launched "SameYou", a charity aiming to offer treatment to those recovering from stroke and brain...
Read more

Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO

Mar 23, 2019 , CNBC Health
Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass...
Read more

Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value

Mar 23, 2019 , CNBC Health
Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's...
Read more

Humana turns to game theory for new Medicare pricing as insurers juggle Trump rebate uncertainty

Mar 23, 2019 , CNBC Health
The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early...
Read more

March 25-29: What Events Are Coming in Health Care

Mar 22, 2019 , Healthcare Business News
March 21—Next week’s healthcare finance events and developments include the deadline to submit comments on changes to the CMS hospital overall star ratings....
Read more

Hospitals Eyeing Outside Partnerships to Counter Disruptors, Leaders Say

Mar 22, 2019 , Healthcare Business News
March 20—Hospital leaders say they no longer are “trying to do a little bit of everything.” Instead, they aim to specialize in some activities while finding outside partners that perform better in other areas....
Read more
Demo

Sugary drinks may help fuel colon cancer tumors, study in mice suggests

Mar 22, 2019 , CNBC Health
The study shows how sugar drives tumor growth, possibly explaining a surge in early colon cancer diagnoses in young...
Read more

Rite Aid shareholders approve reverse stock split

Mar 22, 2019 , CNBC Health
Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock...
Read more

CVS heard from its customers who use CBD, will 'walk slowly' in the space, CEO Larry Merlo says

Mar 22, 2019 , CNBC Health
CVS has started selling CBD, short for cannabidiol products, in eight states. CEO Larry Merlo said CVS will "walk...
Read more

Start-up behind erectile dysfunction website Roman launches health service for women

Mar 21, 2019 , CNBC Health
Ro, the men's health start-up known for straight-to-your-door erectile dysfunction medication, is launching a new service targeting...
Read more

Harvard researchers say certain ADHD medications may increase risk of psychosis

Mar 21, 2019 , CNBC Health
Certain medications commonly used to treat ADHD in teens and young adults may increase their risk of psychosis, according to researchers at Harvard Medical School and McLean...
Read more

CVS has started selling cannabis-based products in 8 states

Mar 21, 2019 , CNBC Health
The pharmacy chain said the products include topicals such as creams, sprays, roll-ons, lotions and...
Read more

Pfizer buys stake in French gene therapy firm Vivet

Mar 21, 2019 , CNBC Health
Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver...
Read more

Value-Based Contracting Not Taking Off: Health Plan Survey

Mar 21, 2019 , Healthcare Business News
March 19—Health plans see a shift to value-based payment on the horizon, according to a new industry survey. It’s a familiar finding....
Read more

Cramer Remix: Forget the stocks caught in the trade war crossfire

Mar 21, 2019 , CNBC Health
Jim Cramer reveals why Nike is an ideal investment that can do well with or without a trade...
Read more